Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: Bluegreen who wrote (14564)	9/15/2000 1:04:58 PM
From: aknahow	Read Replies (1) \| Respond to of 17367

How do you deal with Manfreds point that the 6 hr delay in the hospital prior to injecting Neuprex should not impact mortality in the placebo group and mortality in this group was also lower than expected. I do understand how delays in getting antibiotics and in getting to the hospital lower mortality in both groups by slanting the trial towards survivors. I do not understand why a 6 hr. delay in giving Neuprex would in any way add to the survivability of the placebo group.